Senseonics Holdings (SENS) Stock Price, Quote & News

Company Profile

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for r...

Industry: Medical Devices

Sector: Healthcare

Phone: 301 515 7260

Fax: 833 552 7007

Website: www.senseonics.com

Address:

20451 Seneca Meadows Parkway, Germantown, United States

outofplano Jan. 14 at 11:35 AM

$SENS I actually believe we could achieve 100M revenue in 2026 , I am thinking with pump integration sales should increase +50 pct over company sales projects of 62M, I don’t believe Abbott is going to wait to see sales hit over 100M, they will make their move, before freedom integration, and i suspect offer will be over 2.5B 22-25x sales. CE is icing on the cake. 2027 will be explosive year !!

0 · Reply

Makingsenses Jan. 14 at 3:12 AM

$SENS I so believe there will be a short squeeze. But what is the trigger?

1 · Reply

BMWLTWM3 Jan. 14 at 12:09 AM

$SENS 100 day this week?

0 · Reply

BMWLTWM3 Jan. 14 at 12:02 AM

$SENS Options expire this Friday. Calls to help SP. $8.20+ by EoW January 23 $10.00+ by Earnings March 2, 2026

0 · Reply

darkpoolangel Jan. 13 at 11:31 PM

$SENS 80M should be viable for 2026 revenue. This may only require 20-25K insertions as each insertion can bring roughly 4K revenue. With Twiist and European market and a bit more aggressive marketing is it too much to ask?

2 · Reply

Lupus_Leoque_Holdings Jan. 13 at 10:33 PM

Ayo, here I was thinking our approach was dividend-high, low risk?🤣 $SENS $VZ $UPS $BSWGF $TELO

0 · Reply

Punpire Jan. 13 at 10:31 PM

$SENS I had to open up a escalation with Eversense and called the number on Senseonics website and it kind of looks like Ascensia isn't completely out of the picture yet.

1 · Reply

Lupus_Leoque_Holdings Jan. 13 at 10:21 PM

$SENS Looking for any left over cash in order to average down 🌞💸

0 · Reply

JInvestTrade Jan. 13 at 10:03 PM

$SENS , $DXCM , $TNDM , $PODD , $MDT https://www.linkedin.com/posts/senseonics-inc_senseonics-announces-first-commercial-patients-activity-7416833660223647744-CxCW?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=copy_link

0 · Reply

Punpire Jan. 13 at 9:47 PM

$SENS Broad availability of twiist with Eversense 365 is expected by March 2026. For more information on availability please visit https://www.eversensecgm.com/partners/ or visit.twiist.com/eversense365.

0 · Reply

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

Dec 19, 2025, 10:18 AM EST - 25 days ago

Senseonics: Eversense 365 Is A Game Changer For The CGM Industry

Nov 5, 2025, 8:41 PM EST - 2 months ago

Senseonics Holdings, Inc. (SENS) Q3 2025 Earnings Call Transcript

Oct 22, 2025, 4:05 PM EDT - 2 months ago

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

Oct 6, 2025, 4:05 PM EDT - 3 months ago

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Sep 4, 2025, 11:23 AM EDT - 4 months ago

Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript)

Sep 3, 2025, 7:22 PM EDT - 4 months ago

Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics

Sep 3, 2025, 5:17 PM EDT - 4 months ago

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

Aug 6, 2025, 7:42 PM EDT - 5 months ago

Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 5 months ago

Senseonics Holdings, Inc. Reports Second Quarter Financial Results

Jul 16, 2025, 4:05 PM EDT - 6 months ago

Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

Jun 4, 2025, 4:05 PM EDT - 7 months ago

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

May 21, 2025, 5:06 PM EDT - 8 months ago

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

May 21, 2025, 3:35 AM EDT - 8 months ago

Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity

May 15, 2025, 11:12 PM EDT - 8 months ago

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 15, 2025, 4:05 PM EDT - 8 months ago

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 8, 2025, 7:55 PM EDT - 8 months ago

Senseonics Holdings, Inc. (SENS) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 4:05 PM EDT - 9 months ago

Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

Apr 29, 2025, 7:30 AM EDT - 9 months ago

Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)

Mar 3, 2025, 6:29 PM EST - 11 months ago

Senseonics Holdings, Inc. (SENS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 4:05 PM EST - 11 months ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 26, 2025, 7:30 AM EST - 11 months ago

Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care

Feb 13, 2025, 4:05 PM EST - 11 months ago

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 6, 2025, 4:05 PM EST - 1 year ago

Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Jan 8, 2025, 6:12 PM EST - 1 year ago

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

Nov 7, 2024, 6:33 PM EST - 1 year ago

Senseonics Holdings, Inc. (SENS) Q3 2024 Earnings Call Transcript

Oct 16, 2024, 4:30 PM EDT - 1 year ago

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

Oct 10, 2024, 4:10 PM EDT - 1 year ago

Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Eversense 365 Launches in the US: One Year. One CGM.

Sep 17, 2024, 7:00 AM EDT - 1 year ago

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Sep 6, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 6:07 PM EDT - 1 year ago

Senseonics Holdings, Inc. (SENS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time

Jun 21, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

Jun 13, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

May 29, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

May 13, 2024, 7:52 PM EDT - 1 year ago

Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

May 13, 2024, 4:04 PM EDT - 1 year ago

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

May 9, 2024, 4:05 PM EDT - 1 year ago

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

May 2, 2024, 8:05 AM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

Apr 30, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Eversense® CGM System Receives iCGM Designation by the US FDA

Mar 12, 2024, 7:00 AM EDT - 2 years ago

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

Mar 8, 2024, 8:05 AM EST - 2 years ago

Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

Mar 6, 2024, 8:05 AM EST - 2 years ago

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference

Feb 29, 2024, 7:34 PM EST - 2 years ago

Senseonics Holdings, Inc. (SENS) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:05 PM EST - 2 years ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 15, 2024, 4:05 PM EST - 2 years ago

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time

outofplano Jan. 14 at 11:35 AM

0 · Reply

Makingsenses Jan. 14 at 3:12 AM

$SENS I so believe there will be a short squeeze. But what is the trigger?

1 · Reply

BMWLTWM3 Jan. 14 at 12:09 AM

$SENS 100 day this week?

0 · Reply

BMWLTWM3 Jan. 14 at 12:02 AM

$SENS Options expire this Friday. Calls to help SP. $8.20+ by EoW January 23 $10.00+ by Earnings March 2, 2026

0 · Reply

darkpoolangel Jan. 13 at 11:31 PM

2 · Reply

Lupus_Leoque_Holdings Jan. 13 at 10:33 PM

Ayo, here I was thinking our approach was dividend-high, low risk?🤣 $SENS $VZ $UPS $BSWGF $TELO

0 · Reply

Punpire Jan. 13 at 10:31 PM

$SENS I had to open up a escalation with Eversense and called the number on Senseonics website and it kind of looks like Ascensia isn't completely out of the picture yet.

1 · Reply

Lupus_Leoque_Holdings Jan. 13 at 10:21 PM

$SENS Looking for any left over cash in order to average down 🌞💸

0 · Reply

JInvestTrade Jan. 13 at 10:03 PM

0 · Reply

Punpire Jan. 13 at 9:47 PM

0 · Reply

ParabolicWhisper Jan. 13 at 8:46 PM

$CYCU $WOK $GNPX $SENS sik

0 · Reply

MoneyGroupLLC Jan. 13 at 5:29 PM

Enter: $SENS Calls Strike Price: $8 Expiry Date: FEB 20 2026 Buy in Price: $0.80 - $1.05 Sell Price: $1.50 Profit : +87% (Turn every $1 into $1.87) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/

0 · Reply

knowalittle Jan. 13 at 4:11 PM

$SENS I would appreciate any response of where support exists. Support as I see it, and care not to mention, is so low based on price action that I cannot believe my own TA analysis. I keep reconsidering adding to my relatively large holdings, never selling, and overweighted in SENS, because of my belief the tech will win in spite of executive management Wallstreet & financial incompetence.

1 · Reply

InterStellarStacks Jan. 13 at 3:32 PM

$SENS

0 · Reply

dlp02446 Jan. 13 at 2:48 PM

$SENS I believe they've provided updates in each conference call. Not sure why they would need to come out and tell people regularly that they're still waiting. The Conformité Européenne is bought daily in Europe, just as the FDA approval is in the US. If you have the money to throw their way, things miraculously expedite themselves, whether they are safe or not...look at DXCM's devices. SENS doesn't have that money, so it's a sit and wait situation. I would think knowledgeable investors in this space would already know that.

0 · Reply

firefox2778 Jan. 13 at 1:14 PM

$SENS if this wasn’t Sens, I’ll start adding to my position. Chart signaling to buy, but, because Tim is in charge, I’ll pass on that signal. Already have enough shares and not putting more money into it or risk more. Not worth the pain. I could eventually trade some calls but that’s it.

0 · Reply

londoneast Jan. 13 at 6:13 AM

$SENS Europe has approximately twice the population of the United States and a comparable prevalence of diabetes. After almost eleven months, what is the current status of the CE Mark approval process? Investors were advised to expect approval before the end of 2025. Given the significance of this milestone, is it not appropriate to provide a substantive update? This is a market with the potential to generate up to three times the sales, yet it remains inaccessible until CE Mark approval is granted.

1 · Reply

tomwade Jan. 13 at 3:34 AM

$SENS consistent increasing sales, revenue, new best of breed product driving income streams up and expenses down…

0 · Reply

tomwade Jan. 12 at 10:14 PM

$SENS Best of Breed hidden jem for Diabetics being recognized

0 · Reply

Alderson95 Jan. 12 at 8:00 PM

$SENS we’ve hit the new resistance level

1 · Reply

StocktwitsMaxx Jan. 12 at 7:37 PM

$SENS Was haben die nur aus der Aktie gemacht... die müsste sich bei den News doch mal richtig bewegen...

0 · Reply

outofplano Jan. 12 at 6:40 PM

$SENS all we need to do is say we are using AI, like DXCM, lol. good numbers from sensonics

0 · Reply

Market Cap	342.17M
Revenue (ttm)	22.47M
Net Income (ttm)	-78.62M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-349.89%
Debt to Equity Ratio	0.37

Volume	6,378,656
Avg Vol	7,343,204
Day's Range	N/A - N/A
Shares Out	814.68M
Stochastic %K	20%
Beta	0.83
Analysts	Sell
Price Target	$1.43